Cargando…
Toxicity of Chimeric Antigen Receptor T Cells and its Management
Recently, chimeric antigen receptor (CAR) T cell therapy has transformed the treatment armamentarium of relapsed/refractory B lymphoid malignancies. CAR T cells provide an excellent response rate and potential cure for these patients. However, CAR T cells also possess unique and potentially life-thr...
Autores principales: | Wudhikarn, Kitsada, Soh, Shui Yen, Huang, He, Perales, Miguel-Angel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asia-Pacific Blood and Marrow Transplantation Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847268/ https://www.ncbi.nlm.nih.gov/pubmed/36713468 http://dx.doi.org/10.31547/bct-2021-011 |
Ejemplares similares
-
Infectious complications, immune reconstitution, and infection prophylaxis after CD19 chimeric antigen receptor T-cell therapy
por: Wudhikarn, Kitsada, et al.
Publicado: (2022) -
Cardiotoxicity from chimeric antigen receptor-T cell therapy for advanced malignancies
por: Totzeck, Matthias, et al.
Publicado: (2022) -
The activities and regulatory landscape of cellular therapies including hematopoietic cell transplantation in the world
por: Okamoto, Shinichiro, et al.
Publicado: (2022) -
Obsessive-compulsive disorder and its related disorders: a
reappraisal of obsessive-compulsive spectrum concepts
por: Murphy, Dennis L., et al.
Publicado: (2010) -
Neurobiology of cannabinoid receptor signaling
por: Lutz, Beat
Publicado: (2020)